e-THEMIS

Saint-germain-en-laye, France Founded: 2001 • Age: 25 yrs Acquired
Diversified drugs are distributed by e-THEMIS in pharmaceutical markets.

About e-THEMIS

e-THEMIS is a Healthcare company based in Saint-germain-en-laye (France) founded in 2001. Diversified drugs are distributed by e-THEMIS in pharmaceutical markets. Its chief executive, as recorded, is Hubert Bournier. The company has since been acquired. e-THEMIS offers products and services including Sage X3 Integration and Consulting Services. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include EUROTRANSPHARMA, TRIDEM Pharma and Nutravalia.

Company details

Founded in 2001, e-THEMIS functions as a distributor of diversified pharmaceutical products. Operations focus on supplying a range of drugs to various sectors, with headquarters details not specified. Leadership is provided by CEO Hubert Bournier. The company maintains an online presence through e-themis.com, supporting distribution activities across unspecified geographic areas. Sector involvement remains centered on pharmaceuticals without additional services noted.

  • Headquarters Saint-germain-en-laye, France
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website e-themis.com
  • Social LinkedIn X Facebook
Key Metrics

Products & Services of e-THEMIS

e-THEMIS offers a comprehensive portfolio of products and services, including Sage X3 Integration and Consulting Services.

Sage X3 Integration
ERP Software

Services for implementing enterprise resource planning systems

Consulting Services
Business Advisory

Expert guidance on digitalization and sector-specific solutions

Investors in e-THEMIS

e-THEMIS has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include 4CAD Group.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
4CAD Group is engaged in distributing and integrating industrial digital solutions.
20044cadgroup.comNantes, France
Premium access

Investor details for e-THEMIS

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of e-THEMIS

1 people are tracked at e-THEMIS (1 in leadership).

NameRoleGroup
Hubert Bournier
CEOLeadership
Premium access

Complete people profiles for e-THEMIS

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of e-THEMIS

e-THEMIS has 3 listed competitors in our database. They include EUROTRANSPHARMA, TRIDEM Pharma and Nutravalia.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
eurotranspharma.com2011Clermont-ferrand, France
Offers secure pharmaceutical distribution and last mile logistics services across Europe.
tridem-pharma.com1986Escalquens, France
Pharmaceuticals are distributed by TRIDEM Pharma in France and Europe.
nutravalia.com2015Mougins, France
Manufacturer and distributor of food supplements, cosmetics, pharmaceutical, herbal teas, and derived products
Premium access

Detailed competitors of e-THEMIS

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about E-Themis

Premium access

Complete news archive for e-THEMIS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about e-THEMIS

e-THEMIS was founded in 2001.

e-THEMIS is headquartered in Saint-germain-en-laye, France. It is registered at Saint-germain-en-laye, Ile-de-france, France.

Hubert Bournier is the CEO of e-THEMIS, as recorded in our data.

Founded in 2001, e-THEMIS functions as a distributor of diversified pharmaceutical products. Operations focus on supplying a range of drugs to various sectors, with headquarters details not specified. Leadership is provided by CEO Hubert Bournier. The company maintains an online presence through e-themis.com, supporting distribution activities across unspecified geographic areas. Sector involvement remains centered on pharmaceuticals without additional services noted.

e-THEMIS's top competitors include TRIDEM Pharma, Nutravalia and EUROTRANSPHARMA.

e-THEMIS offers Sage X3 Integration and Consulting Services.

e-THEMIS has 1 investor. Key investors include 4CAD Group.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available